Skip to main content

BON · Bon Natural Life Ltd · Metrics

Track BON — free
$1.13 -0.01 (-0.88%) At close · Nov 12 Q4 2022 earnings call transcript
Market Cap
$9.23M
Shares
8.17M
Volume · Nov 12 7707 Avg daily vol (3M) 8814

BON metrics

67 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.13
Market cap
$9.23M

Price action

23 metrics
Price change (1W)
+1.8%
Price change (30D)
+1.8%
Price change (3M)
-0.9%
Price change (6M)
-6.6%
Price change (YTD)
-28.3%
Price change (1Y)
-41.8%
Trailing year
Price change (5Y)
—
52-week high
$1.96
52-week low
$1.05
Change from 52-week high
-41.8%
Change from 52-week low
+8.6%
Annualized volatility
44.5%
Annualized volatility (3M)
29.6%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.0
RSI (14D)
51.6
Price vs SMA 50
-0.7%
Price vs SMA 200
-10.5%
Avg volume (3M)
8,763
Relative volume
0.5
Average dollar volume
$10,074

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
8.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 202.1%
P / book
0.2
reciprocal yield 545.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
0.9
reciprocal yield 116.6%
Earnings yield
-122.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2022-09-30

Profitability

9 metrics
Gross margin
22.1%
Operating margin
-55.7%
Trailing 12 months
Net margin
-60.4%
Gross profit (TTM)
$4.16M
Operating profit (TTM)
−$10.48M
Net income (TTM)
−$11.37M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$276.45

Growth

11 metrics
Revenue growth YoY
-21.7%
Year over year
Net income growth YoY
-601.0%
Revenue (TTM)
$18.82M
Trailing 12 months
EPS growth YoY
-117.4%
Shares change YoY
+2,766.6%
Year over year · more shares
Revenue CAGR (3Y)
-14.5%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-44.8%

Quality

14 metrics
Return on equity
-22.4%
Return on assets
-14.2%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
−$9.22M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
-23.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.18M
Total assets
$80.20M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$10.86M
Capital expenditures (TTM)
—
R&D (TTM)
$1.44M
SG&A (TTM)
—
Stock compensation (TTM)
$1.16M
R&D / revenue
7.6%
Stock compensation / revenue
6.1%

Ownership (13F)

9 metrics
13F filers
6
13F filer change QoQ
+2
Institutional ownership
0.5%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+147.8%
Holder tenure
1.4
Price vs estimated holder cost
-14.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1816815 CUSIP G14492204 13F (30d) 3 filings 3 filers Visit website Investor relations